M&A Deal Summary

Lupin Acquires Temmler Pharma & Co. KG

On July 24, 2015, Lupin acquired medical products company Temmler Pharma & Co. KG from Aenova Group

Acquisition Highlights
  • This is Lupin’s 1st transaction in the Medical Products sector.
  • This is Lupin’s 1st transaction in Germany.

M&A Deal Summary

Date 2015-07-24
Target Temmler Pharma & Co. KG
Sector Medical Products
Buyer(s) Lupin
Sellers(s) Aenova Group
Deal Type Divestiture

Target

Temmler Pharma & Co. KG

Marburg, Germany
Temmler Pharma GmbH & Co. KG is a provider of Central Nervous System (CNS) products and specialty products that address rare disease areas like Myasthenia Gravis, Huntington disease as well as fast-growing dermatology products for anti-wart treatment.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Lupin

Mumbai, India

Category Company
Founded 1968
Sector Life Science
Employees24,006
Revenue 221.9B INR (2025)
DESCRIPTION

Lupin is an innovation-led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, APIs and biotechnology products. Lupin was founded in 1968 and is based in Mumbai, Maharashtra.


DEAL STATS #
Overall 5 of 11
Sector: Medical Products M&A 1 of 2
Type: Divestiture M&A Deals 1 of 3
Country: Germany M&A 1 of 1
Year: 2015 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-02 Biocom ZAO

Russia

Biocom ZAO is a pharmaceutical company.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-09 GAVIS Pharmaceuticals

Somerset, New Jersey, United States

GAVIS Pharmaceuticals LLC is a provider of pharmaceutical products in a variety of dosage forms.

Buy -

Seller(S) 1

SELLER

Aenova Group

Starnberg, Germany

Category Company
Founded 1949
Sector Life Science
DESCRIPTION

Aenova Group GmbH is a providers of services covering the entire value chain for the development and production of all the main dosage forms and product groups in the field of medicines and dietary supplements.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2015 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-01 Temmler Pharma & Co. KG

Marburg, Germany

Temmler Pharma GmbH & Co. KG is a provider of Central Nervous System (CNS) products and specialty products that address rare disease areas like Myasthenia Gravis, Huntington disease as well as fast-growing dermatology products for anti-wart treatment.

Buy -